Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Molecular Metabolism|September 27, 2022
Nicotinamide riboside kinase 1 protects against diet and age-induced pancreatic β-cell failureAngelique Cercillieux, Joanna Ratajczak, Magali Joffraud, et al.
Scientific Reports|May 31, 2012
Muscle or liver-specific Sirt3 deficiency induces hyperacetylation of mitochondrial proteins without affecting global metabolic homeostasisPablo J Fernandez-Marcos, Ellen H Jeninga, Carles Canto, et al.
Nature Communications|September 22, 2019
Endogenous nicotinamide riboside metabolism protects against diet-induced liver damageAudrey Sambeat, Joanna Ratajczak, Magali Joffraud, et al.
Molecular Metabolism|November 27, 2019
A reduced form of nicotinamide riboside defines a new path for NAD<sup>+</sup> biosynthesis and acts as an orally bioavailable NAD<sup>+</sup> precursorJudith Giroud-Gerbetant, Magali Joffraud, Maria Pilar Giner, et al.
Cell Metabolism|April 5, 2011
PARP-2 regulates SIRT1 expression and whole-body energy expenditurePéter Bai, Carles Canto, Attila Brunyánszki, et al.
Cell Metabolism|May 10, 2024
A human omentum-specific mesothelial-like stromal population inhibits adipogenesis through IGFBP2 secretionRadiana Ferrero, Pernille Yde Rainer, Marie Rumpler, et al.
The American Journal of Clinical Nutrition|August 3, 2019
Persistent low body weight in humans is associated with higher mitochondrial activity in white adipose tissueYiin Ling, Jérôme Carayol, Bogdan Galusca, et al.
Nature Communications|March 26, 2026
Therapeutic potential of dihydronicotinamide riboside (NRH) on obesity and glucose intolerance in miceMarie Rumpler, Guido van Mierlo, Kasper T Vinten, et al.
Nature Aging|September 9, 2025
Emerging strategies, applications and challenges of targeting NAD<sup>+</sup> in the clinicJianying Zhang, He-Ling Wang, Sofie Lautrup, et al.
Pageof 3